susan m. domchek, md: parp inhibitor clinical trials update at aacr 2012
Published 12 years ago • 1.4K plays • Length 8:37Download video MP4
Download video MP3
Similar videos
-
2:38
seminar clips: parp inhibitors and brrca1/2 cancers- susan domchek, md | stanford cancer institute
-
3:23
susan m. domchek, md: the importance of genetic testing
-
57:02
stanford cancer institute breakthroughs in cancer: susan domchek, md
-
12:13
diane simeone, md: pancreatic cancer overview and treatment update from aacr 2012
-
1:45
ask dr. domchek: enhancing parp inhibitors
-
10:03
biopsy and other procedures can cause cancer metastases
-
7:19
my story/ pancreatic cancer
-
22:26
triple-negative breast cancer: what's new in treatment and research at mbc patient forum 2019
-
2:59
meet potamkin prize awardee: susan domchek, m.d.
-
54:43
dr. susan domchek, md - executive director, basser center for brca, abramson cancer center, penn
-
0:37
dr. domchek discusses unanswered questions from the mediola trial
-
13:12
patrick hwu, md: melanoma overview at aacr 2012
-
1:25
what are clinical trials?
-
3:44
q&a: what about parp inhibitors?
-
12:53
beth y. karlan, md: parp inhibitors and ovarian cancer
-
2:37
what is a parp inhibitor?
-
9:53
parp inhibitors for prostate cancer with moshe ornstein, md
-
4:55
breast cancer breakthroughs: positive trial
-
10:01
jose baselga, md, phd: pi3 kinaise inhibitor update
-
0:54
dr. domchek on the mediola trial in breast cancer
-
29:51
evaluating clinical pathways for ovarian cancer treatment and maintenance therapy